Skip to content
DataLookout
Menu

NCT07811258

Improving Adherence to Chronic Disease Medication Regimens Among Patients With Recently Diagnosed Cancer

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary endpoint(s) modified.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened
    • Start date pushed from Sep 7, 2026 to Nov 30, 2026
    • Study sites: 0 to 1
  2. Notable Primary endpoint(s) modified
    • Secondary endpoints revised (4)
    • Study title shortened, about 3 words
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Feasibility, as measured by number of participants recruited
Timeframe: 6 months
Feasibility, as measured by screening to enrollment ratio
Timeframe: from screening to enrollment, approximately 2 weeks
Feasibility, as measured by completion rate of the comprehensive medication review
Timeframe: from enrollment to completion of 6 month follow up
Feasibility, as measured by completion rate of the adherence log
Timeframe: 3 months
Acceptability, as measured by Acceptability of Intervention Measure
Timeframe: 3 months, 6 months
Usability, as measured by the System Usability Score of the Medisafe application
Timeframe: 3 months, 6 months
Patient-centeredness, as measured by the Patient-Centered Care Questionnaire
Timeframe: 3 months
Patient-centeredness, as measured by the Patient-Centered Outcomes Questionnaire
Timeframe: 3 months

Secondary (4)

Quality of life, as measured by the 20-item Short Form Survey
Financial well-being, as measured by the Comprehensive Score for Financial Toxicity
Patient activation, as measured by the Patient Activation Measure
Adherence, as measured by the Adherence to Refills Medication Scale

Arms and interventions

Intervention ArmExperimental

Pharmacist-led medication review plus Medisafe app support.

Control ArmNo intervention

Usual care.

Behavioral: Medisafe Medication Management Program, Pharmacist-Led Medication Review

Sites

1 site in 1 country

  • Duke UniversityDurham, North Carolina, United States